YORHAVEN
"YORHAVEN" is a word mark owned by CSL Behring GmbH, filed at the USPTO on February 1, 2023. It was abandoned and covers class 5 (Pharmaceuticals).
- Status
- Abandoned
- Since July 15, 2025
- Filed
- February 1, 2023
- Registered
- Not yet
- Priority date
- January 12, 2023
- Claimed from European Union
- Application no.
- 97775852
- Registration no.
- Not yet
- Office
- USPTO
- United States Patent and Trademark Office
- Mark type
- Word mark
- 1 class
Who owns YORHAVEN
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
CSL Behring GmbH
Marburg, Germany
Representative
Scott D. Woldow
Smith, Gambrell & Russell, LLP
What the mark covers
The products and services YORHAVEN is filed for, grouped by Nice class.
Pharmaceutical preparations for treating von Willebrand disease, hemophilia, primary immunodeficiency, hereditary angioedema, fibrinogen deficiency, Alpha 1 antitrypsin deficiency, and inflammatory demyelinating polyneuropathy; blood plasma; blood plasma fractions; recombinant protein arrays for medical diagnosis purposes; Pharmaceutical preparations for the treatment and prevention of blood and bleeding disorders; blood products for the treatment of hemophilia, namely, pharmaceutical preparations for the treatment of hemophilia; pharmaceutical products derived from recombinant DNA technology for the treatment of hemophilia, namely, pharmaceutical preparations derived from recombinant DNA technology for the treatment of hemophilia; blood products for the treatment of hemophilia, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; pharmaceutical preparations and substances for the treatment of blood disorders; antibodies, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; blood for medical purposes; cell cultures for medical purposes, namely, cells for medical or clinical use; cell cultures for medical purposes, namely, living cells for medical use; cell cultures for medical purposes, namely, stem cells for medical or veterinary use; pharmaceutical preparations for the treatment of blood conditions, respiratory conditions, pneumonia, covid-19, and influenza; Pharmaceutical preparations, namely, antibody for the treatment of acute respiratory distress syndrome, ARDS; pharmaceutical preparations, namely, antibody for the treatment of Idiopathic Pulmonary Fibrosis, IPF and Interstitial Lung Diseases, ILD; Pharmaceutical preparations, namely, antibody for the treatment of Hereditary Angioedema, HAE
What has happened so far
Steps recorded by the USPTO, newest first.
- Abandonment notice e-mailed - inter partes decision
- Abandonment - after inter partes decision
- Opposition terminated no. 999999
- Opposition dismissed no. 999999
- Extension of time to oppose process - terminated
- Opposition instituted no. 999999
- Extension of time to oppose received
- Official gazette publication confirmation e-mailed
- Published for opposition
- Notification of notice of publication e-mailed
10 earlier steps on the official record.
Oppositions and cancellations
Proceedings recorded against this mark by the USPTO. Reported as recorded, not legal advice.
About YORHAVEN
Who owns the trademark "YORHAVEN"?
The USPTO trademark "YORHAVEN" (application 97775852) is owned by CSL Behring GmbH.
What is the status of "YORHAVEN"?
Its status at the USPTO is: abandoned.
Get this data via the API
Everything on this page comes from the Signa API. Pull YORHAVEN and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019d2b55-d09c-71fe-b0b3-fcac5e930f3f
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019d2b55-d09c-71fe-b0b3-fcac5e930f3f",
"object": "trademark",
"mark_text": "YORHAVEN",
"status": {
"primary": "inactive",
"stage": "abandoned"
},
"office_code": "US",
"application_number": "97775852",
"filing_date": "2023-02-01",
"nice_classes": [
5
],
"owners": [
{
"name": "CSL Behring GmbH",
"entity_id": "ent_019eb6f7-2013-757e-9375-c0720a3cb498"
}
]
}